ALX Oncology Holdings Stock (NASDAQ: ALXO) stock price, news, charts, stock research, profile.
Open | $2.21 |
Close | $2.17 |
Volume / Avg. | 401.61K / 1.28M |
Day Range | $2.14 - $2.26 |
52 Wk Range | 1.88 - 17.83 |
Market Cap | $114.35M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 32.86% |
Days to Cover | 12.85 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ALX Oncology Holdings (NASDAQ:ALXO) through any online brokerage.
Other companies in ALX Oncology Holdings’s space includes: Anixa Biosciences (NASDAQ:ANIX), Citius Oncology (NASDAQ:CTOR), Adicet Bio (NASDAQ:ACET), Agenus (NASDAQ:AGEN) and Eledon Pharma (NASDAQ:ELDN).
ALX Oncology Holdings has a consensus price target of $17.57.
The stock price for ALX Oncology Holdings (NASDAQ: ALXO) is $2.1709 last updated September 19, 2024 at 5:24 PM EDT.
There are no upcoming dividends for ALX Oncology Holdings.
ALX Oncology Holdings’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for ALX Oncology Holdings.
ALX Oncology Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.